Hematology:
Myelofibrosis — Bone marrow transplantation. Treatment abroad

Myelofibrosis is a malignant blood disorder caused by stem cell mutations. This disorder causes a gradual replacement of normal bone marrow tissue with scar (fibrous) tissues. The tumor symptoms are easily confused with other pathologies, and thus a leading role in its diagnostics is played by laboratory and instrumental research methods.

Procedure

The diagnosis is established by a hematologist or oncologist. During the first visit, the physician clarifies complaints, conducts clinical examination and collects the case history. If there is suspicion for myelofibrosis, the patient is prescribed:

  1. Complete blood count. The patients show changes in the size and shape of blood cells (anisotropy and poikilocytosis). The leukocyte content of the blood increases, and so does the platelet content at the later stages of the disease.
  2. Blood chemistry. It helps diagnosing the liver dysfunctions accompanying the myelofibrosis development.
  3. Cytogenetic analysis. Various staining techniques allow detecting mutations associated with malignant disease in the genome of hematopoietic cells.
  4. Abdominal ultrasound. Populating the liver and spleen, cancerous cells provoke an increase in their size.
  5. Comprehensive CT/MRI. With the help of visual diagnostic methods, the physician determines the extent to which the tumor process spread throughout the body.
  6. Bone marrow aspiration biopsy (ilium wing punch biopsy). A sample of the patient’s bone marrow is taken and sent for histological examination. According to the test findings, the tumor nature is established.

In the course of diagnostics, the symptomatic therapy is administered, which helps alleviating the disease symptoms. According to the test findings, the physician establishes an accurate diagnosis and provides recommendations for further treatment.

Read more
 

Sort by:

University Hospital Bonn

8.6/10 from 150 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The key objective of the Department of Internal Medicine III is to create and offer optimal treatments for internal diseases on inpatient, partially inpatient and outpatient basis.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Bonn

Price 195268.00

University Hospital Cologne

8.7/10 from 82 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department I for Internal Medicine of the University Hospital Cologne deals with the treatment of patients with various internal diseases. This includes in particular the following fields: Oncology, Hematology, Clinical infectology, Clinical immunology, Hemostasis, Intensive care.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Cologne

Price 195052.00

University Hospital Frankfurt

7.5/10 from 97 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department of Hematology, Oncology, Hemostasis, Rheumatology and Infectology at the University Hospital Frankfurt specializes in the treatment of all diseases of the hymatopoietic system and solid tumors.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Frankfurt am Main

Price 227626.00

Charite University Hospital Berlin

9/10 from 95 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Charité Comprehensive Cancer Center integrates the clinical and research activities for all Charité departments and institutes dealing with Cancer. The director of the Charité Comprehensive Cancer Center is Prof. Dr. med. Ulrich Keilholz.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Berlin

Price 276595.00

University Hospital Heidelberg

9/10 from 57 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department of Hematology, Oncology and Rheumatology at the Heidelberg University Hospital makes every effort to provide medical care of the highest quality to the patients with oncologic and rheumatologic diseases.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Heidelberg

Krankenhaus Nordwest

9.5/10 from 24 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

Department of Oncology and Hematology of Krankenhaus Nordwest offers a wide range of medical services, including diagnosis, therapy and treatment of oncological diseases or diseases closely associated with the circulatory system.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Frankfurt am Main

Price 178951.00

Städtisches Klinikum Schwabing

8.5/10 from 7 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department of Hematology, Oncology, Immunology, Palliative Medicine, Infectious Diseases and Tropical Medicine in Schwabing treats all benign blood diseases, disorders of the immune and coagulation system, all forms of blood cancer, and the most of cancers.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Munich

Price 178690.00

RWTH University Hospital Aachen

8.7/10 from 41 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department of Oncology, Hematology and Stem Cell Transplant provides patient care on both inpatient and outpatient basis. The focuses of the inpatient treatment are acute leukemia and high-dose chemotherapy followed by autologous blood stem cell transplantation.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Aachen

Price 178756.00

Alfried Krupp Hospital in Essen-Ruettenscheid

9.9/10 from 42 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The main treatment areas of the Department of Internal Medicine I, headed by Prof. Dr. med. Thomas Budde, are invasive and non-invasive cardiac diagnostics and therapy of all cardiac diseases.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Essen

Price 162939.00

University Hospital Dusseldorf

9.9/10 from 71 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department of Hematology, Oncology and Clinical Immunology at the University Hospital Dusseldorf provides treatment of patients with blood diseases, cancer and immune system diseases. The Department focuses on the treatment of malignant diseases of  blood, bone marrow and lymph nodes. .


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Duesseldorf

Price 227539.00

Hannover Medical School, MHH

9.8/10 from 43 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The clinic of hematology, hemostasis, oncology and stem cell transplantation is a leading therapeutic clinic of the Medical Institute of Hannover for patients with solid tumor and systemic diseases, with other partially benign diseases of the hematopoietic system, as well as bleeding disorders.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Hannover

Price 195066.00

Städtisches Klinikum Neuperlach

9.8/10 from 11 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The department of hematology and oncology diagnosed and treated malignant tumors. The therapeutic spectrum includes all medicamentous treating methodes including chemotherapy, antibody, immune and hormone therapy. Cancer patients benefit from interdisciplinary treatment.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Munich

Price 178702.00

Gummersbach District Hospital of the Klinikum Oberberg

9.6/10 from 23 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department of Internal Medicine II at the Klinikum Oberberg in Gummersbach focuses on diagnosis and treatment of oncological and hematological diseases.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Gummersbach

Price 162732.00

University Hospital Halle (Saale)

9.5/10 from 78 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Department of Internal Medicine IV (Hematology and Oncology) covers the whole range of hematology and oncology. This includes prevention, diagnosis, therapy and post-operative care for cancer of all organs and blood.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Halle

Price 195168.00

UKGM Gießen

9.5/10 from 35 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The department of internal medicine IV and V includes general internal medicine and a number of priority areas of this subject. The clinic offers a wide range of newest innovative treatments especially in the fields of medical oncology, hematology and palliative care.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Giessen

Price 178672.00

University Hospital Hamburg-Eppendorf

9.2/10 from 92 Votes

Allogeneic bone marrow transplantation (stem cell transplant) in Myelofibrosis

The Medical Department II at the University Medical Center Hamburg-Eppendorf specializes in the treatment of patients with cancer of the internal organs and hematopoietic system. There is provided the whole range of treatments for these diseases.


Duration 57 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Hamburg

Price 276671.00